Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
作者信息
Jiang Haifeng, Su Hang, Zhang Changchun, Liu Xuebing, Li Ruihua, Zhong Na, Zhao Min
机构信息
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
出版信息
Eur Neuropsychopharmacol. 2020 Jun;35:136-137. doi: 10.1016/j.euroneuro.2020.03.018. Epub 2020 Apr 13.
Abstract
摘要
相似文献
1
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.中国新冠疫情期间美沙酮维持治疗面临的挑战：政策与服务建议
Eur Neuropsychopharmacol. 2020 Jun;35:136-137. doi: 10.1016/j.euroneuro.2020.03.018. Epub 2020 Apr 13.
2
TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.是时候重新审视美国在新冠疫情期间针对阿片类药物使用障碍药物治疗的不均衡政策了。
Addiction. 2020 Oct;115(10):1978-1979. doi: 10.1111/add.15143. Epub 2020 Jul 1.
3
Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?新冠疫情的教训：我们终于准备好让阿片类药物治疗变得可及了吗？
J Subst Abuse Treat. 2020 Oct;117:108074. doi: 10.1016/j.jsat.2020.108074. Epub 2020 Jul 6.
4
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).优化 COVID-19（SARS-CoV-2）期间阿片类药物使用障碍的药物治疗。
J Addict Med. 2020 Jul/Aug;14(4):e1-e3. doi: 10.1097/ADM.0000000000000678.
5
Opioid Use Disorder and COVID-19: Crashing of the Crises.阿片类药物使用障碍与 COVID-19：危机的碰撞。
J Addict Med. 2020 Jul/Aug;14(4):e6-e7. doi: 10.1097/ADM.0000000000000684.
6
President's message: Will COVID-19 have a lasting impact on opioid treatment program regulations?主席致辞：新冠疫情会对阿片类药物治疗项目法规产生持久影响吗？
J Addict Dis. 2020 Jul-Sep;38(3):239-240. doi: 10.1080/10550887.2020.1795335. Epub 2020 Jul 28.
7
Opioids: The Forgotten Epidemic?阿片类药物：被遗忘的流行病？
Tex Med. 2020 Oct 1;116(10):32-35.
8
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.阿片类药物使用障碍的药物治疗和社区药房：在全国性流行和全球大流行期间扩大护理。
Subst Abus. 2020;41(3):269-274. doi: 10.1080/08897077.2020.1787300.
9
The model of epidemic (COVID-19) prevention and control in rural of China.中国农村地区的疫情（新冠肺炎）防控模式
Crit Care. 2020 Apr 14;24(1):146. doi: 10.1186/s13054-020-02874-x.
10
Challenges and Lessons for Managing Glaucoma during COVID-19 Pandemic: Perspectives from Asia.新冠疫情期间青光眼管理的挑战与经验教训：来自亚洲的视角
Ophthalmology. 2020 Sep;127(9):e63-e64. doi: 10.1016/j.ophtha.2020.05.042. Epub 2020 May 29.
引用本文的文献
1
Social support status and associated factors among methadone maintenance patients: a multicentre, cross-sectional study in Vietnam during the COVID-19 pandemic.美沙酮维持治疗患者的社会支持状况及相关因素：COVID-19大流行期间越南的一项多中心横断面研究
BMJ Open. 2024 Dec 27;14(12):e081519. doi: 10.1136/bmjopen-2023-081519.
2
Benefits and challenges experienced by participants on long-term methadone maintenance treatment in China: a qualitative study.中国长期美沙酮维持治疗参与者的获益和挑战：一项定性研究。
BMC Med. 2024 Jan 8;22(1):18. doi: 10.1186/s12916-023-03203-z.
3
Trends and associated factors of HIV, HCV and syphilis infection among different drug users in the China-Vietnam border area: an 11-year cross-sectional study (2010-2020).中越边境地区不同吸毒人群 HIV、HCV 和梅毒感染的趋势及相关因素：一项 11 年的横断面研究（2010-2020 年）。
BMC Infect Dis. 2023 Sep 4;23(1):575. doi: 10.1186/s12879-023-08239-3.
4
Psychological sequelae within different populations during the COVID-19 pandemic: a rapid review of extant evidence.COVID-19 大流行期间不同人群的心理后遗症：现有证据的快速综述。
Singapore Med J. 2022 May;63(5):229-235. doi: 10.11622/smedj.2020111. Epub 2020 Jul 30.
5
Impact on and adaptations by the national addictions management service in response to the COVID-19 pandemic.国家成瘾管理服务部门针对新冠疫情所受到的影响及做出的调整。
Singapore Med J. 2023 Jun;64(6):407-409. doi: 10.11622/smedj.2021231.
6
Changes in methadone take-home dosing before and after COVID-19.美沙酮带药回家剂量在新冠疫情前后的变化。
J Subst Abuse Treat. 2022 Feb;133:108552. doi: 10.1016/j.jsat.2021.108552. Epub 2021 Jun 24.
7
Effect of Coronavirus Disease 2019 on the Psychology and Behavior of Patients on Methadone Maintenance Treatment in Wuhan, China: A Clinical Observational Study.2019年冠状病毒病对中国武汉美沙酮维持治疗患者心理及行为的影响：一项临床观察研究
Front Psychiatry. 2021 Mar 30;12:653662. doi: 10.3389/fpsyt.2021.653662. eCollection 2021.
8
Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic.在 2019 冠状病毒病大流行期间维持阿片类药物使用障碍的治疗和预防计划。
Curr Opin Psychiatry. 2021 Jul 1;34(4):369-375. doi: 10.1097/YCO.0000000000000708.
9
COVID-19 Impact on Healthcare and Supportive Services for People Who Use Drugs (PWUDs) in Malaysia.新冠疫情对马来西亚吸毒者医疗保健及支持性服务的影响
Front Psychiatry. 2021 Mar 29;12:630730. doi: 10.3389/fpsyt.2021.630730. eCollection 2021.
10
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.大流行期间减少危害干预措施和信息传递对注射毒品者的快速证据审查：对正在进行的 COVID-19 应对的影响。
Harm Reduct J. 2020 Dec 1;17(1):95. doi: 10.1186/s12954-020-00445-5.
本文引用的文献
1
A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations.新冠疫情期间中国人心理困扰的全国性调查：启示与政策建议
Gen Psychiatr. 2020 Mar 6;33(2):e100213. doi: 10.1136/gpsych-2020-100213. eCollection 2020.
2
Online mental health services in China during the COVID-19 outbreak.新冠疫情期间中国的在线心理健康服务。
Lancet Psychiatry. 2020 Apr;7(4):e17-e18. doi: 10.1016/S2215-0366(20)30077-8. Epub 2020 Feb 19.
3
Challenges to Opioid Treatment Programs After Hurricane Sandy: Patient and Provider Perspectives on Preparation, Impact, and Recovery.桑迪飓风后阿片类药物治疗项目面临的挑战：患者与提供者对准备、影响及恢复的看法
Subst Use Misuse. 2018 Jan 28;53(2):206-219. doi: 10.1080/10826084.2016.1267225. Epub 2017 Mar 15.
4
Who uses methadone services in China? Monitoring the world's largest methadone programme.谁在中国使用美沙酮服务？监测世界上最大的美沙酮计划。
Addiction. 2015 Jan;110 Suppl 1:29-39. doi: 10.1111/add.12781.
Zotero 插件